Boonmak Suhattaya, Boonmak Polpun, Laopaiboon Malinee
Department of Anaesthesiology, Faculty ofMedicine, Khon Kaen University, Khon Kaen, Thailand.
Cochrane Database Syst Rev. 2013 Jun 6(6):CD006623. doi: 10.1002/14651858.CD006623.pub2.
Functional endoscopic sinus surgery (FESS) is a minimally invasive technique that is used to treat chronic sinusitis. Small bleeding areas can reduce operative visibility and result in destruction of surrounding structures. Deliberate hypotension (lowering the mean arterial blood pressure to between 50 and 65 mm Hg in normotensive patients) using a range of pharmacological agents during general anaesthesia reduces blood loss in many operations.
We aimed to compare the use of the intravenous anaesthetic agent propofol versus other techniques for deliberate hypotension during FESS with regard to blood loss and operative conditions.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 1), MEDLINE (1950 to April 2012), EMBASE (1980 to April 2012), LILACS (1982 to April 2012) and ISI Web of Science (1946 to April 2012). We also searched the reference lists of relevant articles and conference proceedings and contacted the authors of included trials.
We sought all randomized controlled trials (RCTs) conducted to compare propofol with other techniques. Our primary outcome was total blood loss (TBL). Other outcomes included surgical field quality, operation time, mortality within 24 hour, complications and failure to reach target blood pressure.
Two review authors independently extracted details of trial methodology and outcome data from reports of all trials considered eligible for inclusion. All analyses were made on an intention-to-treat basis where possible. When I(2) was < 40% and the P value from the Chi(2) test was > 0.10, we pooled data by using the fixed-effect model. Otherwise we pooled data by using the random-effects model.
We included four studies with 278 participants in the review. Deliberate hypotension with propofol did not decrease TBL (millilitres) when compared with inhalation anaesthetics in either children or adults. Propofol improved the quality of the surgical field by less than one category on a scale from 0 (no bleeding) to 5 (severe bleeding) (mean difference (MD) 0.64 better with propofol, 95% confidence interval (CI) 0.37 to 0.91 better), but no difference in operation time was reported. Failure to lower blood pressure to target was less common in the propofol group (relative risk of failure with propofol (RR) 0.24, 95% CI 0.09 to 0.66).
AUTHORS' CONCLUSIONS: Using propofol to achieve deliberate hypotension may improve the surgical field, but the effect is small. Deliberate hypotension with propofol did not decrease TBL and operation time. RCTs with good quality methodology and large sample size are required to investigate the effectiveness of deliberate hypotension with propofol for FESS.
功能性鼻内镜鼻窦手术(FESS)是一种用于治疗慢性鼻窦炎的微创技术。小的出血区域会降低手术视野清晰度,并导致周围结构的破坏。在全身麻醉期间使用一系列药理学药物进行控制性低血压(将血压正常患者的平均动脉血压降至50至65毫米汞柱之间)可减少许多手术中的失血量。
我们旨在比较静脉麻醉药丙泊酚与其他控制性低血压技术在FESS期间的失血量和手术条件。
我们检索了Cochrane对照试验中心注册库(CENTRAL)(《Cochrane图书馆》2012年第1期)、MEDLINE(1950年至2012年4月)、EMBASE(1980年至2012年4月)、LILACS(1982年至2012年4月)和科学引文索引(ISI)数据库(1946年至2012年4月)。我们还检索了相关文章和会议论文集的参考文献列表,并联系了纳入试验的作者。
我们查找了所有比较丙泊酚与其他技术的随机对照试验(RCT)。我们的主要结局是总失血量(TBL)。其他结局包括手术视野质量、手术时间、24小时内死亡率、并发症以及未达到目标血压的情况。
两位综述作者独立从所有被认为符合纳入标准的试验报告中提取试验方法细节和结局数据。所有分析尽可能基于意向性分析。当I²<40%且卡方检验的P值>0.10时,我们使用固定效应模型合并数据。否则,我们使用随机效应模型合并数据。
我们在综述中纳入了四项研究,共278名参与者。与吸入麻醉药相比,丙泊酚控制性低血压在儿童或成人中均未降低TBL(毫升)。丙泊酚将手术视野质量从0(无出血)至5(严重出血)的等级改善不到一个等级(丙泊酚更好的平均差值(MD)为0.64,95%置信区间(CI)为更好0.37至0.91),但未报告手术时间有差异。丙泊酚组未将血压降至目标值的情况较少见(丙泊酚失败的相对风险(RR)为0.24,95%CI为0.09至0.66)。
使用丙泊酚实现控制性低血压可能会改善手术视野,但效果较小。丙泊酚控制性低血压并未减少TBL和手术时间。需要高质量方法学和大样本量的RCT来研究丙泊酚控制性低血压用于FESS的有效性。